New patent will allow for the relief of chronic neuropathic pain

October 27, 2017, University of Seville
University of Seville and GB Sciences Inc. members meet to license the patent. Credit: University of Seville

The researchers Lucía Martín Banderas and Mercedes Fernández Arévalo, from the I+DNanomed research group at the University of Seville, have patented an innovative formulation based on nanotechnology, which is designed to relieve chronic neuropathic pain. The company GB Sciences, Inc. has obtained the exclusive global intellectual property licence for the use of this patent.

This research group, in collaboration with the researchers J.A. Micó and E. Berrocoso, of the University of Cadiz and the Mental Health Networking Biomedical Research Centre (CIBERSAM), has shown that its formulation of controlled liberation of a derived cannabinoid provides neuropathic pain relief in rats for a period of eleven days after the oral administration of a single dose. Part of the results of this project have recently been published in the review Nanomedicine: Nanotechnology, Biology and Medicine.

Within the framework of this global licensing agreement, the University of Seville research group I+DNanomed, led by Dr Mercedes Fernández Arévalo, has signed an agreement to work on research projects with the company for the development of innovative formulations based on polymer nanoparticles with active ingredients developed by GB Sciences for the treatment of chronic pain.

The University of Seville researchers' creation makes it possible, via the use of nanotechnology, to encapsulate the main active ingredients in a polymer matrix composite. In this way, it is possible to extend the therapeutic effect while reducing the dose of medicine it is necessary to administer. In addition, the cannot cross the blood-brain barrier, which removes any potential psychoactive effect.

GB Sciences has highlighted the advance that the development of this technique signifies. The contribution of the University of Seville researchers Mercedes Fernández Arévalo and Lucía Martín Banderas to the development of new more effective systems for the development of type of molecule, based on nanotechnology, is going to mean a very important advance in the treatment of chronic pain. According to one of the company's managers, "Their system has proven to be more effective than other methods, such as inhalation or ingestion, for administering these composites".

Explore further: Scientists discover powerful potential pain reliever

More information: Esther Berrocoso et al, Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days, Nanomedicine: Nanotechnology, Biology and Medicine (2017). DOI: 10.1016/j.nano.2017.07.010

Related Stories

Scientists discover powerful potential pain reliever

August 16, 2017
A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway. The synthetic ...

Scientists discover new category of analgesic drugs that may treat neuropathic pain

March 29, 2017
New research published online in The FASEB Journal suggests that a novel therapeutic target called LPCAT2 may prove effective against pain that is not receptive to the current treatments. This study has also revealed the ...

Questions remain about the benefits and harms of cannabis

April 3, 2017
Despite dramatic changes in the legal landscape and usage rates of cannabis, evidence is still lacking regarding its potential health and therapeutic effects. Recently, the National Academies of Sciences, Engineering, and ...

Potential drug for treating chronic pain with few side effects

July 31, 2017
Researchers at Okayama University describe in the Proceedings of the National Academy of Sciences the effect of clodronate on the regulation of adenosine triphosphate release and its potential as a drug for the treatment ...

Team suggests Corydalis yanhusuo extract for use as an adjunct medicine for low-moderate chronic pain

September 14, 2016
Root extracts from the flowering herbal plant Corydalis yanhusuo, or YHS, has widely used for centuries as a pain treatment. Yet few studies have investigated how it works on different forms of pain, and little is known about ...

Neurotoxin in cigarette smoke worsens pain in spinal cord injuries

June 15, 2017
Researchers have identified a key component in cigarette smoke that worsens pain in people with spinal cord injury, suggesting that a critical element within tobacco is responsible for such pain-inducing effects.

Recommended for you

Leg exercise is critical to brain and nervous system health

May 23, 2018
Groundbreaking research shows that neurological health depends as much on signals sent by the body's large, leg muscles to the brain as it does on directives from the brain to the muscles. Published today in Frontiers in ...

Mechanisms of harmful overhydration and brain swelling

May 22, 2018
We are all familiar with the drawbacks of dehydration, but we rarely hear about the harmful effects of overhydration. For one, excess fluid accumulation can lead to dangerously low sodium levels in the blood or hyponatremia—a ...

Mice brain structure linked with sex-based differences in anxiety behavior

May 22, 2018
Using male individuals has long been a tradition in scientific mice studies. But new research enforces the importance of using a balanced population of male and female mice.

In brain stimulation therapy less might be more

May 22, 2018
One of the promising non-invasive brain therapeutic methods is the repetitive transcranial magnetic stimulation (rTMS). During such a procedure, a magnetic coil is placed near the head of the patient and a magnetic pulse ...

Subtle hearing loss while young changes brain function, study finds

May 22, 2018
Cranking up your headphones or scrambling for a front-row spot at rock shows could be damaging more than your hearing.

What helps form long-term memory also drives the development of neurodegenerative disease

May 22, 2018
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in Amyotrophic Lateral Sclerosis (ALS). This small part of the Ataxin-2 protein ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.